Close
American Drug Delivery & Formulation Summit
Xylem

News

Innovations In Quality Control For Pharmaceutical Production

The needs of manufacturing facilities, tools, and procedures must be suitable for this new environment as the focus of new drug research shifts toward innovative medicines and vaccines. Young biotechโ€™s face new hurdles when they scale up production, while...

6 Pharma, Biotech Patent Litigation Trends To Watch In 2023

Who will file a lawsuit under the UPC first? The deadline for opting out of patents will begin on March 1, 2023, and the UPC will begin on June 1, 2023. The schedule was recently changed in response to allegations...

New Zealand Health Groups Strive To Enhance Clinical Trials

Based on recommendations from an independent study report titled Enhancing Aotearoa New Zealand Clinical Trials, New Zealand's top health agencies will examine system-level adjustments to enhance the benefits from clinical trials. The report was created by a broad team of...

Syneos Health Extends Partnership with Medable

Syneos Health, the only fully integrated biopharmaceutical solutions organization, announced it has extended its strategic partnership with Medable, the industry-leading technology platform for patient-centered clinical trials, as part of the Companyโ€™s commitment to bring clinical trials closer to the...

Hovione and GEA announce a strategic collaboration to advance Continuous Tableting

Hovione and GEA announced a strategic collaboration to advance Continuous Tableting. This partnership stemmed from a successful customer-supplier relationship spanning several years. It combines GEAยดs engineering expertise with Hovioneยดs development and manufacturing experience and both parties commit to partner...

Hyperparathyroidism: Symptoms, Causes and Treatment

Hyperparathyroidism is an extremely prevalent endocrine disorder. Recent studies reveal that about 80% of people in Western countries suffer from parathyroids. Additionally, about 1,00,000 people in the United States show symptoms yearly. A person suffering from the disease tends to...

Canadian And US Pharma Firms To Test Psychedelic Drugs In UK

To take advantage of the UK's quick medication approval procedures, the North American psychedelic drug companies Mindset, PharmAla, Mydecine, and Psyence have inked a contract with the clinical research organisation (CRO) Clerkenwell Health to test treatments for mental health...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป